Earnings Preview For Lucid Diagnostics
Portfolio Pulse from Benzinga Insights
Lucid Diagnostics (NASDAQ:LUCD) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $-0.27. Investors are looking for an earnings beat and positive guidance for future growth. Historically, LUCD's stock price has been sensitive to earnings performance and guidance. Last quarter, LUCD beat the EPS estimate by $0.05, resulting in a 0.34% stock price increase the following day. Over the past year, LUCD shares have declined by 50.44%.
November 10, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lucid Diagnostics is anticipated to report an EPS of $-0.27 for the upcoming earnings release. Historical data shows that earnings beats or misses and guidance can significantly impact LUCD's stock price.
The expected EPS is a key indicator of the company's performance, and past trends show that LUCD's stock price can be influenced by earnings results and guidance. However, the score is neutral (0) due to the lack of information on whether the expectations will be met or exceeded.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100